Question 1

What does Epirus Biopharmaceuticals do?

Accepted Answer

Epirus Biopharmaceuticals develops biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.

Question 2

In what sectors does Epirus Biopharmaceuticals operate?

Accepted Answer

Epirus Biopharmaceuticals operates in Biotechnology, Life Science, Therapeutics.

Question 3

How many companies has Epirus Biopharmaceuticals acquired?

Accepted Answer

Epirus Biopharmaceuticals has made 2 acquisitions between 2014-2015, with a total disclosed deal value of $14.1M.

Question 4

What companies are owned by Epirus Biopharmaceuticals?

Accepted Answer

Companies acquired by Epirus Biopharmaceuticals include Bioceros, Zalicus.

Question 5

What are Epirus Biopharmaceuticals's major acquisitions?

Accepted Answer

Epirus Biopharmaceuticals's largest acquisitions include Bioceros ($14.1M, 2015).

Question 6

What is Epirus Biopharmaceuticals's largest acquisition?

Accepted Answer

Epirus Biopharmaceuticals's largest disclosed acquisition is Bioceros for $14.1M (2015).

Question 7

What was Epirus Biopharmaceuticals's first acquisition?

Accepted Answer

Epirus Biopharmaceuticals's first recorded acquisition was Zalicus in 2014.

Question 8

What was Epirus Biopharmaceuticals's most recent acquisition?

Accepted Answer

Epirus Biopharmaceuticals's most recent acquisition is Bioceros, announced September 2015 for $14.1M.

Question 9

What is the average deal size for Epirus Biopharmaceuticals acquisitions?

Accepted Answer

The average disclosed deal size for Epirus Biopharmaceuticals acquisitions is $14.1M.

Question 10

What is the median deal size for Epirus Biopharmaceuticals acquisitions?

Accepted Answer

The median disclosed deal size for Epirus Biopharmaceuticals acquisitions is $14.1M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Epirus Biopharmaceuticals spent on acquisitions?

Accepted Answer

Epirus Biopharmaceuticals has spent at least $14.1M across its disclosed acquisitions (of 2 total deals; some prices are undisclosed).

Question 12

Which sector has Epirus Biopharmaceuticals spent the most on?

Accepted Answer

Epirus Biopharmaceuticals has committed the most disclosed capital to Biopharma companies — about $14.1M across its deals in that sector.

Question 13

What sectors does Epirus Biopharmaceuticals usually acquire in?

Accepted Answer

Epirus Biopharmaceuticals most frequently acquires companies in Biotechnology, Health Care, Biopharma.

Question 14

In which sector has Epirus Biopharmaceuticals made the most acquisitions?

Accepted Answer

Epirus Biopharmaceuticals has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Epirus Biopharmaceuticals make the most acquisitions?

Accepted Answer

Epirus Biopharmaceuticals made the most acquisitions in 2015, with 1 deal.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Epirus Biopharmaceuticals

Company Details

Funding & Financials

Web Traffic

Company Info

Acquisitions by Epirus Biopharmaceuticals

Key People at Epirus Biopharmaceuticals

Explore 200,000+ acquisitions — free

Recent News related to Epirus Biopharmaceuticals

FAQs about Epirus Biopharmaceuticals

People who checked this page also checked these